Choose a language and wait for the translated text.
Sales of anti-infectives rose to ₹2,359 crore in July 2026 from ₹2,107 crore in June, while those of antibacterials increased to ₹2,109 crore from ₹1,883 crore. Sales of both the segments were up 6% from July 2025.
